Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers
✍ Scribed by Julian Ananiev; Maya Gulubova; Georgi Tchernev; Mariana Penkova; Radostina Miteva; Alexander Julianov; Irena Manolova
- Book ID
- 106173005
- Publisher
- Springer Vienna
- Year
- 2011
- Tongue
- English
- Weight
- 683 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0043-5325
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Alterations in TGF‐β signaling appear to be associated with an altered risk of developing cancer, including breast cancer. We carried out a case‐control study on 8 polymorphisms, including 5 in the __TGF‐β1__ gene (G‐800A, C‐509T, Leu^10^→Pro, Arg^25^→Pro and Thr^263^→Ile), a polyalanin
Various osteoblastic cell lines were examined for the relationship between the presence of cell-surface transforming growth factor (TGF)-P receptors and the synthesis of matrix proteins with their responsiveness to TGF-P. Treatment with TGF-PI inhibited proliferation and stimulated proteoglycan and
Transforming growth factor-beta (TGF-P) is a polypeptide with multiple physiological functions. lsoforms of this growth factor have important roles in control of the cell cycle, in regulation of cell-cell interactions and in growth and development. Malignant transformation has been shown to be assoc